An ETA receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Darusentan

Item No. 36034

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
αS-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-benzenepropanoic acid
CAS Number
171714-84-4
Synonyms
  • HMR 4005
  • Lu 135252
Molecular Formula
C22H22N2O6
Formula Weight
410.4
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMF: 10 mg/mlDMSO: 2 mg/mlEthanol: 2 mg/mlPBS (pH 7.2): insol
SMILES
COC1=NC(O[C@H](C(O)=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)=NC(OC)=C1
InChi Code
InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
InChi Key
FEJVSJIALLTFRP-LJQANCHMSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $39

    Add

    5 mg

    $136

    Add

    10 mg

    $231

    Add

    25 mg

    $530

    Add
    Product Description

    Darusentan is an endothelin type A (ETA) receptor antagonist (Ki = 13 nM in rat aortic vascular smooth muscle cells).1 It inhibits contractions induced by human endothelin-1 (ET-1; Item No. 24127) in isolated rat aortic rings and mesenteric microvessels with pA2 values of 8.1 and 7.97, respectively. Darusentan (50 mg/kg) decreases systolic blood pressure in DOCA-salt hypertensive rats, as well as reduces mean arterial pressure (MAP) and left ventricular developed pressure (LVDP) in normotensive pigs when administered at doses of 1 and 5 mg/kg.2,3 It reduces myocardial infarct size as a percentage of the area at risk in a porcine model of ischemia-reperfusion injury induced by ligation of the left anterior descending (LAD) coronary artery.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liang, F., Glascock, C.B., Schafer, D.L., et al. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries. Can. J. Physiol. Pharmacol. 88(8), 840-849 (2010).

    2. Schiffrin, E.L., Turgeon, A., and Deng, L.Y. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br. J. Pharmacol. 121(5), 935-940 (1997).

    3. Gonon, A.T., Wang, Q.D., Shimizu, M., et al. The novel non-peptide selective endothelin A receptor antagonist LU 135 252 protects against myocardial ischaemic and reperfusion injury in the pig. Acta Physiol. Scand. 163(2), 131-137 (1998).